1. Home
  2. JAGX vs IMTE Comparison

JAGX vs IMTE Comparison

Compare JAGX & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • IMTE
  • Stock Information
  • Founded
  • JAGX 2013
  • IMTE 2008
  • Country
  • JAGX United States
  • IMTE Malaysia
  • Employees
  • JAGX N/A
  • IMTE N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • IMTE Consumer Electronics/Appliances
  • Sector
  • JAGX Health Care
  • IMTE Consumer Staples
  • Exchange
  • JAGX Nasdaq
  • IMTE Nasdaq
  • Market Cap
  • JAGX 3.1M
  • IMTE 5.1M
  • IPO Year
  • JAGX N/A
  • IMTE N/A
  • Fundamental
  • Price
  • JAGX $4.55
  • IMTE $1.46
  • Analyst Decision
  • JAGX
  • IMTE
  • Analyst Count
  • JAGX 0
  • IMTE 0
  • Target Price
  • JAGX N/A
  • IMTE N/A
  • AVG Volume (30 Days)
  • JAGX 40.9K
  • IMTE 6.4M
  • Earning Date
  • JAGX 03-31-2025
  • IMTE 04-15-2025
  • Dividend Yield
  • JAGX N/A
  • IMTE N/A
  • EPS Growth
  • JAGX N/A
  • IMTE N/A
  • EPS
  • JAGX N/A
  • IMTE N/A
  • Revenue
  • JAGX $11,689,000.00
  • IMTE $123,337.00
  • Revenue This Year
  • JAGX $18.18
  • IMTE N/A
  • Revenue Next Year
  • JAGX $40.06
  • IMTE N/A
  • P/E Ratio
  • JAGX N/A
  • IMTE N/A
  • Revenue Growth
  • JAGX 19.75
  • IMTE 4.75
  • 52 Week Low
  • JAGX $4.40
  • IMTE $0.51
  • 52 Week High
  • JAGX $540.00
  • IMTE $3.84
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 20.14
  • IMTE 51.67
  • Support Level
  • JAGX $4.41
  • IMTE $1.47
  • Resistance Level
  • JAGX $4.97
  • IMTE $1.82
  • Average True Range (ATR)
  • JAGX 0.83
  • IMTE 0.41
  • MACD
  • JAGX 0.16
  • IMTE 0.03
  • Stochastic Oscillator
  • JAGX 1.86
  • IMTE 35.71

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About IMTE Integrated Media Technology Limited

Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.

Share on Social Networks: